Association between single-point insulin sensitivity estimator and hypertension stratified by glycemic status among US adults: a cross-sectional study

The single-point insulin sensitivity estimator (SPISE) is a validated surrogate for insulin sensitivity derived from triglycerides (TG), high-density lipoprotein cholesterol (HDL-C), and body mass index (BMI). Its relationship with hypertension, and whether that relationship depends on glycemic status, remains unclear. We examined the association between SPISE and hypertension among United States adults. This study analyzed data from 27,563 adults aged 20 to 85 years (mean age 49.0 ± 17.7 years, 49.6% men) who participated in seven consecutive cycles of the National Health and Nutrition Examination Survey from 2005 to 2018. SPISE was calculated as 600 × HDL-C 0.185 / (TG 0.2 × BMI 1.338 ), with HDL-C and TG in mg/dL and BMI in kg/m². Hypertension was ascertained from measured blood pressure, self-reported physician diagnosis, or antihypertensive medication use. The association was assessed using logistic regression across three progressively adjusted models, with SPISE entered both continuously and in quartiles. Restricted cubic splines (RCS) and piecewise regression characterized the dose-response relationship, and analyses were stratified by glycemic status with a formal test of interaction. Hypertension was present in 12,430 participants (45.1%). Higher SPISE was associated with lower odds of hypertension in every model, with a fully adjusted odds ratio of 0.79 (95% CI 0.78 to 0.80) per one-unit increment and 0.26 (95% CI 0.24 to 0.29) for the highest quartile, showing a significant trend across quartiles. RCS revealed a nonlinear pattern, and piecewise regression identified an exploratory inflection point at a SPISE of 5.025, below which the inverse association was steeper. The association was of similar magnitude in normoglycemia, prediabetes, and diabetes (odds ratio 0.82 in each stratum), and the formal interaction test did not support effect modification by glycemic status (P for interaction = 0.933). Higher SPISE was independently associated with lower odds of prevalent hypertension, and this association was consistent across the glycemic spectrum. Prospective studies are needed to establish the temporal nature of this association.

Authors

Institutions

Publication Details

Journal
Diabetology & Metabolic Syndrome
Published
2026-11-18
DOI
https://doi.org/10.1186/s13098-026-02351-5
Primary Topic
Diabetes, Cardiovascular Risks, and Lipoproteins
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Association between single-point insulin sensitivity estimator and hypertension stratified by glycemic status among US adults: a cross-sectional study

Fuad A. Abdu
Diabetology & Metabolic Syndrome
Diabetes, Cardiovascular Risks, and Lipoproteins
article

Association between single-point insulin sensitivity estimator and hypertension stratified by glycemic status among US adults: a cross-sectional study

Fuad A. Abdu
article en

Abstract

The single-point insulin sensitivity estimator (SPISE) is a validated surrogate for insulin sensitivity derived from triglycerides (TG), high-density lipoprotein cholesterol (HDL-C), and body mass index (BMI). Its relationship with hypertension, and whether that relationship depends on glycemic status, remains unclear. We examined the association between SPISE and hypertension among United States adults. This study analyzed data from 27,563 adults aged 20 to 85 years (mean age 49.0 ± 17.7 years, 49.6% men) who participated in seven consecutive cycles of the National Health and Nutrition Examination Survey from 2005 to 2018. SPISE was calculated as 600 × HDL-C 0.185 / (TG 0.2 × BMI 1.338 ), with HDL-C and TG in mg/dL and BMI in kg/m². Hypertension was ascertained from measured blood pressure, self-reported physician diagnosis, or antihypertensive medication use. The association was assessed using logistic regression across three progressively adjusted models, with SPISE entered both continuously and in quartiles. Restricted cubic splines (RCS) and piecewise regression characterized the dose-response relationship, and analyses were stratified by glycemic status with a formal test of interaction. Hypertension was present in 12,430 participants (45.1%). Higher SPISE was associated with lower odds of hypertension in every model, with a fully adjusted odds ratio of 0.79 (95% CI 0.78 to 0.80) per one-unit increment and 0.26 (95% CI 0.24 to 0.29) for the highest quartile, showing a significant trend across quartiles. RCS revealed a nonlinear pattern, and piecewise regression identified an exploratory inflection point at a SPISE of 5.025, below which the inverse association was steeper. The association was of similar magnitude in normoglycemia, prediabetes, and diabetes (odds ratio 0.82 in each stratum), and the formal interaction test did not support effect modification by glycemic status (P for interaction = 0.933). Higher SPISE was independently associated with lower odds of prevalent hypertension, and this association was consistent across the glycemic spectrum. Prospective studies are needed to establish the temporal nature of this association.

Diabetology & Metabolic Syndrome
Shandong Xiehe University (CN)
Good health and well-being
Diabetes, Cardiovascular Risks, and Lipoproteins
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon